nach oben

Journal of Genetic Counseling

Erschienen in:

01.12.2010 | Original Research

Death Anxiety and Symbolic Immortality in Relatives at Risk for Familial Amyloid Polyneuropathy Type I (FAP I, ATTR V30M)

verfasst von: Paula I. Santos, Eurico Figueiredo, Inês Gomes, Jorge Sequeiros

Erschienen in: Journal of Genetic Counseling | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

This study is an investigation of the impact of familial amyloid polyneuropathy type I (FAP I, ATTR V30M) on death anxiety and symbolic immortality. Templer and Drolet’s scales were administered to 524 individuals: (1) 84 relatives at risk, (2) 92 relatives not at risk for FAP I; and (3) a control group (n = 348) with no known hereditary disease in their families. At-risk relatives had, on average, a higher score for death anxiety and a lower score for symbolic immortality, than either those not-at-risk or controls. There were no significant differences in scores on either measure for those not-at-risk versus controls. Being at risk increases death anxiety and threatens the sense of symbolic immortality and psychosocial wellbeing. This may be true for other serious hereditary disorders as well. Genetic counsellors should become familiar with these concepts, feel comfortable initiating discussions about death with their patients, and be able to identify and reinforce their patients’ and family members’ sense of symbolic immortality.

Granville Stanley Hall (1844–1924), first president of the American Psychological Association, founder of the first psychology laboratory in the USA.

Andrade, C. (1952). A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain, 75, 408–427.CrossRefPubMed

Abdel-Khalek, A. (2002). Why do we fear death? The construction and validation of the reasons for death fear scale. Death Studies, 26(8), 80–669.CrossRef

Abdel-Khalek, A., & Lester, D. (2009). Religiosity and death anxiety: no association in Kuwait. Psychological Reports, 104(3), 770–772.CrossRefPubMed

Becker, E. (1973). The denial of death. New York: Free.

Benjamin, C. M., Colley, A., Donnai, D., Kingston, H., Harris, R., & Kerzin-Storrar, L. (1993). Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families. Journal of Medical Genetics, 30(7), 567–574.CrossRefPubMed

Bennings, C. R., & Smith, A. (1994). Psychological needs of family members of liver transplant patients. Clinical Nurse Specialists, 8, 280–288.

Biesecker, B., & Marteau, T. (1999). The future of genetic counselling: an international perspective. Nature Genetics, 22, 133–137.CrossRef

Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: a systematic review. European Journal of Human Genetics, 8, 731–738.CrossRefPubMed

Conte, H., Weiner, M., & Plutchik, R. (1982). Measuring death anxiety: conceptual, psychometric, and factor-analytic aspects. Journal of Personality and Social Psychology, 43(4), 775–785.CrossRefPubMed

Coutinho, P., Silva, A., Lima, J., & Barbosa, A. (1980). Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In P. Coutinho, A. Martins da Silva, J. Kopes Lima & A. Resende Barbosa (Eds.), Amyloid and amyloidosis (pp. 88–98). Amsterdam: Experpta Medica.

Cox, S., & McKellin, W. (2001). There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease. Sociology of Health & Illness, 21(5), 622–646.CrossRef

Drolet, J. L. (1990). Transcending death during early adulthood: symbolic immortality, death anxiety, and purpose in life. Journal of Clinical Psychology, 46(2), 148–160.CrossRefPubMed

Decruyenaere, M., Evers-Kiebooms, G., & Van Den Berghe, H. (1993). Perception of predictive testing for Huntington S Disease by young women: preferring uncertainty to certainty? Journal of Medical Genetics, 30(7), 557–561.CrossRefPubMed

Fanos, J. H., & Johnson, J. P. (1995). Perception of carrier status by cystic fibrosis siblings. American Journal of Human Genetics, 57(2), 431–438.PubMed

Fleming, M., & Lopes, A. (2000). Saber Ou Não Saber: Dinâmica e Impasses Psicológicos Na Doença Genética (P.A.F.). Revista Portuguesa de Psicossomática, 2(1), 33–40.

Florian, V., & Mikulincer, M. (1998). Symbolic immortality and the management of terror of death: the moderation role of attachment style. Journal of Personality and Social Psychology, 74(3), 725–734.CrossRefPubMed

Fortner, B. V., & Neimeyer, R. A. (1999). Death anxiety in older adults: a quantitative review. Death Studies, 23(5), 387–411.CrossRefPubMed

Graceffa, A., Russo, M., Vita, G. L., Toscano, A., Dattola, R., Messina, C., et al. (2009). Psychosocial impact of presymptomatic genetic testing for transthyretin amyloid polyneuropathy. Neuromuscular Disorders, 19(1), 44–48.CrossRefPubMed

Holmgren, G., Ericzon, B. G., Groth, C. G., Steen, L., Suhr, O., Andersen, O., et al. (1993). Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet, 341(8853), 1113–1116.CrossRefPubMed

Jonsen, E., Athlin, E., & Suhr, O. B. (2000). Family members’ experience of familial amyloidotic polyneuropathy disease—an infernal struggle and a fact of life. Journal of Advanced Nursing, 31(2), 347–353.CrossRefPubMed

Lester, D. (2008). What do death anxiety scales measure? Psychological Reports, 101(1), 754.

Lester, D., & Templer, D. I. (1993). Death anxiety scales: a dialogue. Omega, 26(4), 239–353.

Lifton, R. J. (1964). On death and symbolism: the Hiroshima Disaster. Psychiatry, 27, 191–210.PubMed

Lifton, R. J. (1973). Twentieth Annual Karen Horney Lecture. The sense of immortality: on death and the continuity of life. American Journal of Psychoanalysis, 33(1), 3–15.CrossRefPubMed

Lifton, R. J. (1979). The broken connection: on death and the continuity of life. Simon & Schuster, New York.

Lifton, R. J. (1987). The future of immortality and other essays for a nuclear age. New York: Basic Books.

Lifton, R. J. (1991) Death in life: survivors of Hiroxima. The University of North Carolina Press.

Lifton, R. J., & Olson, E. (1974). Living and dying. New York: Praeger.

Lopes, A., & Fleming, M. (1996). Doença Somática e Organização Psíquica: Reflexões A Partir da Polineuropatia Amiloidótica Familiar. Revista Portuguesa de Psicanálise, 15, 93–100.

Lopes, A., & Fleming, M. (1998). Aspectos Psicológicos da Polineuropatia Amiloidótica Familiar: A Trama Subterrânea Intergeracional. Brotéria Genética. XIX(XCIV), 183–192.

Mathews, R. C., & Mister, R. D. (1987–88). Measuring an individual’s investment in the future: symbolic sensation seeking, and psychic numbness. Omega, 18(3), 161–173.

McAllister, M. (2002). Predictive genetic testing and beyond: a theory of engagement. Journal of Health Psychology, 7, 491–508.CrossRef

McAllister, M., Davies, L., Payne, K., Nicholls, S., Donai, D., & Mac Leod, R. (2007). The emotional effects of genetics diseases: implications of clinical genetics. American Journal of Medical Genetics. Part A, 143A, 2651–2661.CrossRefPubMed

McGovern, M., & Barry, M. M. (2000). Death education: knowledge, attitudes, and perspectives of Irish parents and teachers. Death Studies, 24(4), 325–333.CrossRefPubMed

Mikulincer, M., & Florian, V. (2000). Exploring individual differences in reactions to mortality salience: does attachment style regulate terror management mechanisms? Journal of Personality and Social Psychology, 79(2), 260–273.CrossRefPubMed

Neimeyer, R. A., & Moore, M. K. (1994). Validity and reliability for of the multidimentional fear of death scale. In R. A. Neimeyer (Ed.), Death anxiety handbook: research, instrumentation, and application (pp. 103–117). Washington: Taylor & Francis.

Paneque, H. M., Prieto, A. L., Reynaldo, R. R., Cruz, M. T., Santos, F. N., Almaguer, M. L., et al. (2007). Psychological aspects of presymptomatic diagnosis of spinocerebellar ataxia type 2 in Cuba. Community Genetics, 10(3), 132–139.CrossRefPubMed

Powell, F., & Thorson, J. (1991). Construction of death among those high in intrinsic religious motivation: a factor analytic study. Death Studies, 15(2), 131–138.CrossRef

Rolim, L., Leite, A., Lêdo, S., Paneque, M., Sequeiros, J., & Fleming, M. (2006). Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I. Clinical Genetics, 69, 297–305.CrossRefPubMed

Santos, P. I. (1999). Ansiedade perante a morte e imortalidade simbólica: Outro diálogo com os deficientes motores: Lisboa: Tese de Mestrado, Instituto Superior de Psicologia Aplicada, Lisboa.

Saraiva, M. J., Costa, P. P., & Goodman, D. S. (1986). Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy. Neurology, 36(11), 1413–1417.PubMed

Sequeiros, J. (1998). Prenatal diagnosis of late-onset diseases. Progresos en Diagnóstico Prenatal, 10(4), 218–220.

Sequeiros, J., & Saraiva, M. J. (1987). Onset in the seventh decade and lack of symptoms in heterozyotes for the Ttr (Met30). Mutation in hereditary Amyloid Neuropathy-Type I (Portuguese, Andrade). American Journal of Medical Genetics, 27(2), 345–357.CrossRefPubMed

Sousa, A., Coelho, T., Barros, J., & Sequeiros, J. (1995). Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). American Journal of Medical Genetics, 60(6), 512–521.CrossRefPubMed

Suhr, O. B., Holmgren, G., Steen, L., Wikstrom, L., Norden, G., Friman, S., et al. (1995). Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation, 60(9), 933–938.CrossRefPubMed

Templer, D. (1970). The construction and validation of a death anxiety scale. The Journal of General Psychology, 82, 165–177.CrossRefPubMed

Templer, D. I. (1971). Death anxiety as related to depression and health of retired persons. Journal of Gerontology, 26, 228–236.

Templer, D. (1972). Death anxiety and religiously involved person. Psychological Reports, 31(6), 361–362.PubMed

Thorson, J. A., & Powell, F. C. (1988). Elements of death anxiety and meanings of death. Journal of Clinical Psychology, 44, 691–701.CrossRefPubMed

Weil, J. (2000). Psychosocial genetic counselling. Oxford University Press.

Wexler, S. N. (2004). Genetic “Russian Roulette” the experience of being “At Risk” for Huntington’s Disease. Genetic Counselling: Psychological Dimensions, by Academic Press, pp. 199–220.

Wu, A. M., & Tang, C. S. (2009). The negative impact of death anxiety on self-efficacy and willingness to donate organs among Chinese adults. Death Studies, 33(1), 51–72.CrossRefPubMed

Titel: Death Anxiety and Symbolic Immortality in Relatives at Risk for Familial Amyloid Polyneuropathy Type I (FAP I, ATTR V30M)
verfasst von: Paula I. Santos
Eurico Figueiredo
Inês Gomes
Jorge Sequeiros
Publikationsdatum: 01.12.2010
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 6/2010
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-010-9311-3

Neu im Fachgebiet Gynäkologie und Geburtshilfe

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

In Kooperation mit:: Zeitschrift für Allgemeinmedizin, DEGAM

weitere anzeigen

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Death Anxiety and Symbolic Immortality in Relatives at Risk for Familial Amyloid Polyneuropathy Type I (FAP I, ATTR V30M)

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Das Ende der vollständigen axillären Lymphknotendissektion

Wer kümmert sich um STI bei Frauen?

Update Gynäkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Expanding Roles: A Survey of Public Health Genetic Counselors

“It’s Challenging on a Personal Level”—Exploring the ‘Lived Experience’ of Australian and Canadian Prenatal Genetic Counselors

Training the Millennial Learner Through Experiential Evolutionary Scaffolding: Implications for Clinical Supervision in Graduate Education Programs

“What Would You Do if You Were Me?” Effects of Counselor Self-Disclosure Versus Non-disclosure in a Hypothetical Genetic Counseling Session

Impediments to DNA Testing and Cascade Screening for Hypertrophic Cardiomyopathy and Long QT syndrome: A Qualitative Study of Patient Experiences

Awareness, Perceptions, and Provider Recommendation Related to Genetic Testing for Hereditary Breast Cancer Risk among At-Risk Hispanic Women: Similarities and Variations by Sub-Ethnicity

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Das Ende der vollständigen axillären Lymphknotendissektion

Wer kümmert sich um STI bei Frauen?

Update Gynäkologie